Encompass Health Corp Financials

EHC

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 55/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth

Encompass Health Corp's revenue grew 11.9% year-over-year to $5.4B, a solid pace of expansion. This earns a growth score of 63/100.

Leverage

Encompass Health Corp carries a low D/E ratio of 1.14, meaning only $1.14 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 69/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Encompass Health Corp's current ratio of 1.05 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Cash Flow

Encompass Health Corp has a free cash flow margin of 6.7%, earning a moderate score of 34/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Encompass Health Corp earns a strong 22.1% return on equity (ROE), meaning it generates $22 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 88/100. This is up from 21.4% the prior year.

Piotroski F-Score Neutral

6/9

Encompass Health Corp passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.20x

For every $1 of reported earnings, Encompass Health Corp generates $2.20 in operating cash flow ($1.0B OCF vs $455.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

This page shows Encompass Health Corp (EHC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$5.4B

YoY+11.9%

5Y CAGR+3.1%

Encompass Health Corp generated $5.4B in revenue in fiscal year 2024. This represents an increase of 11.9% from the prior year.

EBITDA

N/A

Free Cash Flow

$360.3M

YoY+34.6%

5Y CAGR+6.5%

10Y CAGR+2.4%

Encompass Health Corp generated $360.3M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 34.6% from the prior year.

Net Income

$455.7M

YoY+29.5%

5Y CAGR+4.9%

10Y CAGR+7.5%

Encompass Health Corp reported $455.7M in net income in fiscal year 2024. This represents an increase of 29.5% from the prior year.

EPS (Diluted)

$4.46

YoY+28.5%

5Y CAGR+4.3%

10Y CAGR+6.9%

Encompass Health Corp earned $4.46 per diluted share (EPS) in fiscal year 2024. This represents an increase of 28.5% from the prior year.

Cash & Debt

$85.4M

YoY+23.6%

5Y CAGR+7.3%

10Y CAGR+2.5%

Encompass Health Corp held $85.4M in cash against $2.4B in long-term debt as of fiscal year 2024.

Dividends Per Share

$0.64

YoY+6.7%

5Y CAGR-10.3%

10Y CAGR-2.0%

Encompass Health Corp paid $0.64 per share in dividends in fiscal year 2024. This represents an increase of 6.7% from the prior year.

Shares Outstanding

101M

YoY+0.6%

5Y CAGR+0.5%

Encompass Health Corp had 101M shares outstanding in fiscal year 2024. This represents an increase of 0.6% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

8.5%

YoY+1.1pp

5Y CAGR+0.7pp

Encompass Health Corp's net profit margin was 8.5% in fiscal year 2024, showing the share of revenue converted to profit. This is up 1.1 percentage points from the prior year.

Return on Equity

22.1%

YoY+0.7pp

5Y CAGR-4.5pp

10Y CAGR-24.9pp

Encompass Health Corp's ROE was 22.1% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 0.7 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

$31.1M

5Y CAGR-7.5%

10Y CAGR-3.2%

Encompass Health Corp spent $31.1M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$642.5M

YoY+10.2%

5Y CAGR+11.5%

10Y CAGR+14.2%

Encompass Health Corp invested $642.5M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 10.2% from the prior year.

EHC Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$5.4B+11.9%	$4.8B+10.4%	$4.3B+8.3%	$4.0B+12.6%	$3.6B-22.6%	$4.6B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$209.2M+3.7%	$201.7M+30.7%	$154.3M-9.0%	$169.5M+11.8%	$151.6M-38.6%	$247.0M
Operating Income	N/A	N/A	$539.5M-3.6%	$559.6M-0.8%	$563.9M-7.9%	$612.1M
Interest Expense	$137.4M-4.3%	$143.5M-18.3%	$175.7M+6.9%	$164.3M-10.6%	$183.7M+15.0%	$159.7M
Income Tax	$150.2M+13.6%	$132.2M+32.1%	$100.1M-1.8%	$101.9M+36.4%	$74.7M-35.5%	$115.9M
Net Income	$455.7M+29.5%	$352.0M+29.9%	$271.0M-34.3%	$412.2M+45.0%	$284.2M-20.8%	$358.7M
EPS (Diluted)	$4.46+28.5%	$3.47+28.5%	$2.70-34.3%	$4.11+44.2%	$2.85-21.1%	$3.61

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$1.5B+1.4%	$1.5B+0.2%	$1.5B+3.6%	$1.4B+8.0%	$1.3B-1.1%	$1.3B+5.6%	$1.2B+3.3%	$1.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$56.1M-5.6%	$59.4M+13.6%	$52.3M-4.0%	$54.5M+7.9%	$50.5M+0.6%	$50.2M-5.5%	$53.1M+6.6%	$49.8M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$30.8M+1.3%	$30.4M-4.4%	$31.8M-3.6%	$33.0M-3.8%	$34.3M-2.6%	$35.2M+0.9%	$34.9M-2.8%	$35.9M
Income Tax	$44.9M-12.0%	$51.0M+22.6%	$41.6M+10.6%	$37.6M-1.8%	$38.3M0.0%	$38.3M+3.0%	$37.2M+22.8%	$30.3M
Net Income	$126.5M-11.0%	$142.1M-6.2%	$151.5M+25.3%	$120.9M+6.0%	$114.1M+1.4%	$112.5M+28.4%	$87.6M+2.7%	$85.3M
EPS (Diluted)	$1.24-10.8%	$1.39-6.1%	$1.48+25.4%	$1.18+5.4%	$1.12+1.8%	$1.10+27.9%	$0.86+2.4%	$0.84

EHC Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$6.5B+7.1%	$6.1B+8.3%	$5.6B-17.9%	$6.9B+6.5%	$6.4B+6.0%	$6.1B
Current Assets	$886.9M+5.4%	$841.8M+17.4%	$717.2M-22.2%	$921.4M-2.9%	$948.6M+25.5%	$755.8M
Cash & Equivalents	$85.4M+23.6%	$69.1M+217.0%	$21.8M-55.9%	$49.4M-73.4%	$185.6M+209.3%	$60.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$593.0M-1.1%	$599.8M+14.3%	$524.8M+4.5%	$502.1M-10.8%	$563.0M+12.9%	$498.7M
Goodwill	$1.3B+0.2%	$1.3B+1.4%	$1.3B+2.1%	$1.2B+0.7%	$1.2B+0.8%	$1.2B
Total Liabilities	$3.7B-3.1%	$3.8B+0.8%	$3.8B-15.5%	$4.5B+0.5%	$4.4B+7.1%	$4.1B
Current Liabilities	$841.0M+28.1%	$656.4M+14.0%	$575.9M-23.1%	$748.8M+4.4%	$717.3M-0.5%	$721.0M
Long-Term Debt	$2.4B-12.2%	$2.7B-2.0%	$2.7B-15.4%	$3.2B-0.3%	$3.3B+7.5%	$3.0B
Total Equity	$2.1B+25.5%	$1.6B+25.7%	$1.3B-31.4%	$1.9B+20.4%	$1.6B+17.4%	$1.4B
Retained Earnings	$796.7M+96.0%	$406.5M+251.3%	$115.7M-18.4%	$141.8M+158.5%	-$242.3M+54.0%	-$526.5M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$6.9B+1.2%	$6.8B+2.2%	$6.6B+1.6%	$6.5B+2.3%	$6.4B+2.5%	$6.2B+2.1%	$6.1B+2.3%	$6.0B
Current Assets	$869.8M-5.3%	$918.1M+0.8%	$910.9M+2.7%	$886.9M-5.5%	$938.1M+0.9%	$929.8M+10.5%	$841.8M+3.5%	$813.7M
Cash & Equivalents	$48.7M-50.9%	$99.1M+3.4%	$95.8M+12.2%	$85.4M-44.7%	$154.4M+14.9%	$134.4M+94.5%	$69.1M-30.7%	$99.7M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	$593.0M	N/A	N/A	$599.8M	N/A
Goodwill	$1.3B0.0%	$1.3B+1.5%	$1.3B0.0%	$1.3B0.0%	$1.3B+0.2%	$1.3B0.0%	$1.3B0.0%	$1.3B
Total Liabilities	$3.7B-0.5%	$3.7B-0.2%	$3.7B+0.5%	$3.7B-4.5%	$3.9B+0.8%	$3.8B+0.6%	$3.8B+0.8%	$3.8B
Current Liabilities	$762.0M-11.9%	$865.1M+1.1%	$856.0M+1.8%	$841.0M+21.1%	$694.5M+2.1%	$680.3M+3.6%	$656.4M+2.7%	$639.2M
Long-Term Debt	$2.4B+3.2%	$2.3B-0.6%	$2.3B-1.1%	$2.4B-12.1%	$2.7B+0.1%	$2.7B-0.2%	$2.7B-0.2%	$2.7B
Total Equity	$2.4B+4.1%	$2.3B+5.6%	$2.2B+4.5%	$2.1B+12.4%	$1.8B+5.6%	$1.7B+5.7%	$1.6B+5.6%	$1.6B
Retained Earnings	N/A	N/A	N/A	$796.7M	N/A	N/A	$406.5M	N/A

EHC Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$1.0B+17.9%	$850.8M+20.5%	$705.8M-1.4%	$715.8M+1.6%	$704.7M+10.9%	$635.3M
Capital Expenditures	$642.5M+10.2%	$583.1M+3.2%	$564.8M+7.7%	$524.6M+33.6%	$392.8M+5.5%	$372.4M
Free Cash Flow	$360.3M+34.6%	$267.7M+89.9%	$141.0M-26.3%	$191.2M-38.7%	$311.9M+18.6%	$262.9M
Investing Cash Flow	-$653.3M-8.4%	-$602.8M+3.9%	-$627.0M+5.9%	-$666.3M-63.5%	-$407.5M+38.0%	-$657.4M
Financing Cash Flow	-$330.6M-67.6%	-$197.2M-35.3%	-$145.7M+39.3%	-$240.1M-64.6%	-$145.9M-402.7%	$48.2M
Dividends Paid	$62.8M+4.0%	$60.4M-39.0%	$99.0M-11.8%	$112.2M+0.4%	$111.8M+2.9%	$108.7M
Share Buybacks	$31.1M	$0	$0	$0-100.0%	$6.1M-86.7%	$45.9M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$270.8M+0.2%	$270.2M-6.4%	$288.6M+3.5%	$278.8M+28.2%	$217.4M-9.0%	$238.8M+18.8%	$201.0M-6.6%	$215.2M
Capital Expenditures	$187.1M+19.2%	$156.9M-3.8%	$163.1M-17.9%	$198.7M+26.6%	$156.9M+12.6%	$139.4M-34.2%	$211.7M+41.4%	$149.7M
Free Cash Flow	$83.7M-26.1%	$113.3M-9.7%	$125.5M+56.7%	$80.1M+32.4%	$60.5M-39.1%	$99.4M+1029.0%	-$10.7M-116.3%	$65.5M
Investing Cash Flow	-$201.3M-21.7%	-$165.4M-4.4%	-$158.5M+22.2%	-$203.7M-28.6%	-$158.4M-22.1%	-$129.7M+37.7%	-$208.1M-28.3%	-$162.2M
Financing Cash Flow	-$113.2M-25.5%	-$90.2M+30.8%	-$130.4M+13.6%	-$150.9M-204.2%	-$49.6M-22.2%	-$40.6M-35.8%	-$29.9M+54.6%	-$65.8M
Dividends Paid	$17.0M-0.6%	$17.1M-5.0%	$18.0M+5.9%	$17.0M+14.1%	$14.9M-6.3%	$15.9M+6.7%	$14.9M-0.7%	$15.0M
Share Buybacks	$24.9M+0.8%	$24.7M-23.1%	$32.1M+328.0%	$7.5M-55.4%	$16.8M	$0	$0	$0

EHC Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	12.4%-1.5pp	13.9%-1.9pp	15.8%+2.5pp	13.3%
Net Margin	8.5%+1.1pp	7.3%+1.1pp	6.2%-4.0pp	10.3%+2.3pp	8.0%+0.2pp	7.8%
Return on Equity	22.1%+0.7pp	21.4%+0.7pp	20.7%-0.9pp	21.6%+3.7pp	17.9%-8.6pp	26.5%
Return on Assets	7.0%+1.2pp	5.8%+1.0pp	4.8%-1.2pp	6.0%+1.6pp	4.4%-1.5pp	5.9%
Current Ratio	1.05-0.2	1.28+0.0	1.25+0.0	1.23-0.1	1.32+0.3	1.05
Debt-to-Equity	1.14-0.5	1.63-0.5	2.09+0.4	1.70-0.4	2.05-0.2	2.24
FCF Margin	6.7%+1.1pp	5.6%+2.3pp	3.2%-1.5pp	4.8%-4.0pp	8.8%+3.0pp	5.7%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	8.6%-1.2pp	9.8%-0.7pp	10.4%+1.8pp	8.6%-0.2pp	8.8%+0.2pp	8.6%+1.5pp	7.0%-0.0pp	7.1%
Return on Equity	5.3%-0.9pp	6.2%-0.8pp	7.0%+1.2pp	5.9%-0.3pp	6.2%-0.3pp	6.5%+1.1pp	5.3%-0.2pp	5.5%
Return on Assets	1.8%-0.2pp	2.1%-0.2pp	2.3%+0.4pp	1.8%+0.1pp	1.8%-0.0pp	1.8%+0.4pp	1.4%0.0pp	1.4%
Current Ratio	1.14+0.1	1.060.0	1.060.0	1.05-0.3	1.35-0.0	1.37+0.1	1.280.0	1.27
Debt-to-Equity	1.010.0	1.02-0.1	1.08-0.1	1.14-0.3	1.46-0.1	1.54-0.1	1.63-0.1	1.73
FCF Margin	5.7%-2.1pp	7.8%-0.8pp	8.6%+2.9pp	5.7%+1.1pp	4.7%-2.9pp	7.5%+8.4pp	-0.9%-6.3pp	5.4%

Similar Companies

Univ Health Svc UHS

$14.7B

Fresenius Med Cr FMS

$14.2B

Tenet Healthcare Corp THC

$20.3B

Ensign Group Inc ENSG

$12.4B

Davita Inc DVA

$10.0B

Frequently Asked Questions

What is Encompass Health Corp's annual revenue?

Encompass Health Corp (EHC) reported $5.4B in total revenue for fiscal year 2024. This represents a 11.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Encompass Health Corp's revenue growing?

Encompass Health Corp (EHC) revenue grew by 11.9% year-over-year, from $4.8B to $5.4B in fiscal year 2024.

Is Encompass Health Corp profitable?

Yes, Encompass Health Corp (EHC) reported a net income of $455.7M in fiscal year 2024, with a net profit margin of 8.5%.

What is Encompass Health Corp's earnings per share (EPS)?

Encompass Health Corp (EHC) reported diluted earnings per share of $4.46 for fiscal year 2024. This represents a 28.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Encompass Health Corp have?

As of fiscal year 2024, Encompass Health Corp (EHC) had $85.4M in cash and equivalents against $2.4B in long-term debt.

What is Encompass Health Corp's net profit margin?

Encompass Health Corp (EHC) had a net profit margin of 8.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does Encompass Health Corp pay dividends?

Yes, Encompass Health Corp (EHC) paid $0.64 per share in dividends during fiscal year 2024.

What is Encompass Health Corp's return on equity (ROE)?

Encompass Health Corp (EHC) has a return on equity of 22.1% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Encompass Health Corp's free cash flow?

Encompass Health Corp (EHC) generated $360.3M in free cash flow during fiscal year 2024. This represents a 34.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Encompass Health Corp's operating cash flow?

Encompass Health Corp (EHC) generated $1.0B in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Encompass Health Corp's total assets?

Encompass Health Corp (EHC) had $6.5B in total assets as of fiscal year 2024, including both current and long-term assets.

What are Encompass Health Corp's capital expenditures?

Encompass Health Corp (EHC) invested $642.5M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Does Encompass Health Corp buy back shares?

Yes, Encompass Health Corp (EHC) spent $31.1M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does Encompass Health Corp have outstanding?

Encompass Health Corp (EHC) had 101M shares outstanding as of fiscal year 2024.

What is Encompass Health Corp's current ratio?

Encompass Health Corp (EHC) had a current ratio of 1.05 as of fiscal year 2024, which is considered adequate.

What is Encompass Health Corp's debt-to-equity ratio?

Encompass Health Corp (EHC) had a debt-to-equity ratio of 1.14 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Encompass Health Corp's return on assets (ROA)?

Encompass Health Corp (EHC) had a return on assets of 7.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Encompass Health Corp's Piotroski F-Score?

Encompass Health Corp (EHC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Encompass Health Corp's earnings high quality?

Encompass Health Corp (EHC) has an earnings quality ratio of 2.20x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Encompass Health Corp?

Encompass Health Corp (EHC) scores 55 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.